Cargando…
A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data
BACKGROUND: In Germany, CRT devices with defibrillator capability (CRT-D) have become the predominant treatment strategy for patients with heart failure and cardiac dyssynchrony. However, according to current guidelines, most patients would also be eligible for the less expensive CRT pacemaker (CRT-...
Autores principales: | Hadwiger, Moritz, Schumann, Laura, Eisemann, Nora, Dagres, Nikolaos, Hindricks, Gerhard, Haug, Janina, Wolf, Michael, Marschall, Ursula, Katalinic, Alexander, Frielitz, Fabian-Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438143/ https://www.ncbi.nlm.nih.gov/pubmed/36056371 http://dx.doi.org/10.1186/s12962-022-00384-x |
Ejemplares similares
-
Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
por: Hadwiger, Moritz, et al.
Publicado: (2020) -
Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project
por: Hadwiger, Moritz, et al.
Publicado: (2022) -
Device runtime and costs of cardiac resynchronization therapy pacemakers – a health claims data analysis
por: Hadwiger, Moritz, et al.
Publicado: (2022) -
Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project—a position paper
por: Willems, Dick, et al.
Publicado: (2021) -
The PROFID project
por: Dagres, Nikolaos, et al.
Publicado: (2020)